Brief: Xspray Pharma AB (Publ) - Q4 Earnings Before Tax Amounted Sek -14,972 Thousand
Feb 25 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* XSPRAY PHARMA PUBLISHES INTERIM REPORT Q4, JANUARY – DECEMBER 2020
* XSPRAY PHARMA AB (PUBL) - Q4 EARNINGS BEFORE TAX AMOUNTED TO SEK -14,972 THOUSAND
(-18,738)
* XSPRAY PHARMA AB (PUBL) - Q4 CASH FLOW FROM OPERATING ACTIVITIES AMOUNTED TO SEK -11,717
THOUSAND (-11,546)
Source text for Eikon: ID:nMFN4mL7fk
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003